Knight Therapeutics (KHTRF) Short Interest Ratio & Short Volume $3.62 +0.03 (+0.84%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Knight Therapeutics Short Interest DataKnight Therapeutics (KHTRF) has a short interest of 341,000 shares. This marks a -39.11% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.3, indicating that it would take 7.3 days of the average trading volume of 5,709 shares to cover all short positions.Current Short Interest341,000 sharesPrevious Short Interest560,000 sharesChange Vs. Previous Month-39.11%Dollar Volume Sold Short$1.28 millionShort Interest Ratio7.3 Days to CoverLast Record DateNovember 30, 2024Today's Trading Volume806 sharesAverage Trading Volume5,709 sharesToday's Volume Vs. Average14% Short Selling Knight Therapeutics? Sign up to receive the latest short interest report for Knight Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKHTRF Short Interest Over TimeKHTRF Days to Cover Over TimeKHTRF Percentage of Float Shorted Over Time Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office... I put all the details together for you here — but please hurry. Knight Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024341,000 shares $1.28 million -39.1%N/A7.3 $3.75 11/15/2024560,000 shares $2.06 million +62.2%N/A37.6 $3.69 10/31/2024345,200 shares $1.39 million +34.8%N/A119 $4.04 10/15/2024256,100 shares $1.07 million +17.4%N/A128.1 $4.19 9/30/2024218,100 shares $950,916.00 -0.2%N/A94.8 $4.36 9/15/2024218,600 shares $966,212.00 +5.5%N/A128.6 $4.42 Get the Latest News and Ratings for KHTRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024207,300 shares $852,003.00 +1.3%N/A76.8 $4.11 8/15/2024204,600 shares $840,906.00 -2.7%N/A55.3 $4.11 7/31/2024210,300 shares $868,539.00 -0.8%N/A70.1 $4.13 7/15/2024211,900 shares $885,742.00 -0.4%N/A40 $4.18 6/30/2024212,700 shares $882,705.00 -2.0%N/A44.3 $4.15 6/15/2024217,000 shares $902,720.00 -3.6%N/A433.9 $4.16 5/31/2024225,000 shares $983,475.00 +4.8%N/A59.2 $4.37 5/15/2024214,700 shares $942,533.00 -3.0%N/A55.1 $4.39 4/30/2024221,400 shares $927,666.00 +2.0%N/A82 $4.19 4/15/2024217,000 shares $909,230.00 +3.8%N/A47.2 $4.19 3/31/2024209,100 shares $819,672.00 -0.1%N/A7.1 $3.92 3/15/2024209,300 shares $830,921.00 -10.4%N/A33.8 $3.97 2/29/2024233,600 shares $955,424.00 -8.1%N/A21 $4.09 2/15/2024254,300 shares $1.04 million -0.9%N/A68.7 $4.11 1/15/2024230,500 shares $965,564.50 -2.9%N/A74.3 $4.19 12/31/2023237,300 shares $939,708.00 -2.4%N/A92.4 $3.96 12/15/2023243,100 shares $940,553.90 -45.2%N/A47.7 $3.87 11/30/2023443,500 shares $1.72 million -7.7%N/A119.9 $3.88 11/15/2023480,300 shares $1.81 million -19.4%N/A64.9 $3.76 10/31/2023596,000 shares $1.94 million +103.6%N/A220.7 $3.26 10/15/2023292,800 shares $983,808.00 +11.2%N/A6.6 $3.36 9/30/2023263,400 shares $874,539.10 -32.5%N/A39.3 $3.32 9/15/2023390,400 shares $1.28 million +6.7%N/A61 $3.29 8/31/2023366,000 shares $1.25 million +16.0%N/A8715.1 $3.41 8/15/2023315,600 shares $1.04 million -8.8%N/A3156 $3.31 7/31/2023345,900 shares $1.27 million +19.7%N/A150.4 $3.66 7/15/2023289,100 shares $1.09 million -3.2%N/A321.2 $3.78 6/30/2023298,600 shares $1.08 million +42.3%N/A64.9 $3.62 6/15/2023209,900 shares $761,937.00 -51.7%N/A8.2 $3.63 5/31/2023434,300 shares $1.58 million -29.6%N/A24.3 $3.63 5/15/2023616,700 shares $2.22 million +31.1%N/A1541.8 $3.60 4/30/2023470,400 shares $1.63 million +93.2%N/A470.4 $3.46 4/15/2023243,500 shares $881,470.00 +42.6%N/A19.5 $3.62 3/31/2023170,800 shares $561,078.00 +77.4%N/A27.5 $3.29First JFK… next Elon? (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. 3/15/202396,300 shares $351,495.00 -22.0%N/A53.5 $3.65 2/28/2023123,500 shares $463,495.50 -5.6%N/A19.6 $3.75 2/15/2023130,800 shares $510,460.08 -65.2%N/A1308 $3.90 1/31/2023375,700 shares $1.47 million -16.8%N/A46.4 $3.90 1/15/2023451,300 shares $1.79 million -12.5%N/A161.2 $3.96 12/30/2022515,700 shares $1.96 million +26.0%N/A13.3 $3.80 12/15/2022409,400 shares $1.58 million +69.3%N/A4094 $3.86 11/30/2022241,800 shares $961,880.40 +103.7%N/A2418 $3.98 11/15/2022118,700 shares $472,188.60 -43.1%N/A1187 $3.98 10/31/2022208,500 shares $817,737.00 +37.4%N/A2085 $3.92 10/15/2022151,700 shares $579,038.90 +31.8%N/A758.5 $3.82 9/30/2022115,100 shares $452,688.30 +142.3%N/A115.1 $3.93 9/15/202247,500 shares $220,875.00 -4.6%N/A0 $4.65 8/31/202249,800 shares $231,570.00 +20.3%N/A124.5 $4.65 8/15/202241,400 shares $194,103.90 -42.4%N/A6.2 $4.69 7/31/202271,900 shares $319,955.00 -6.5%N/A359.5 $4.45 7/15/202276,900 shares $332,208.00 -23.8%N/A256.3 $4.32 6/30/2022100,900 shares $401,582.00 -22.2%N/A1009 $3.98 6/15/2022129,600 shares $528,768.00 -19.4%N/A117.8 $4.08 5/31/2022160,700 shares $691,010.00 +10.5%N/A47.3 $4.30 5/15/2022145,400 shares $588,870.00 -2.1%N/A80.8 $4.05 4/30/2022148,500 shares $622,660.50 +2.1%N/A148.5 $4.19 4/15/2022145,500 shares $611,100.00 -51.5%N/A363.8 $4.20 3/31/2022300,100 shares $1.23 million +59.6%N/A1500.5 $4.11 3/15/2022188,000 shares $802,760.00 -8.5%N/A626.7 $4.27 2/28/2022205,500 shares $871,320.00 -6.2%N/A40.3 $4.24 2/15/2022219,000 shares $941,700.00 -33.0%N/A64.4 $4.30 1/31/2022326,900 shares $1.43 million +41.8%N/A155.7 $4.36 1/15/2022230,600 shares $968,520.00 -15.1%N/A2306 $4.20 12/31/2021271,600 shares $1.13 million -5.9%N/A39.9 $4.16 12/15/2021288,500 shares $1.15 million +5.1%N/A72.1 $4.00 11/30/2021274,400 shares $1.12 million -24.0%N/A40.4 $4.10 11/15/2021360,900 shares $1.53 million -14.1%N/A11.2 $4.23 10/29/2021420,100 shares $1.75 million +53.3%N/A131.3 $4.15 10/15/2021274,000 shares $1.18 million -38.8%N/A47.2 $4.32 9/30/2021447,700 shares $1.93 million -7.1%N/A81.4 $4.31 9/15/2021482,000 shares $2.01 million -3.2%N/A150.6 $4.16 8/31/2021497,800 shares $2.11 million -17.6%N/A54.1 $4.25 8/13/2021604,400 shares $2.73 million -6.5%N/A167.9 $4.51 7/30/2021646,700 shares $2.65 million +39.1%N/A6.4 $4.09 7/15/2021464,900 shares $1.94 million +21.9%N/A101.1 $4.18 6/30/2021381,500 shares $1.64 million -34.2%N/A5.5 $4.30 6/15/2021580,000 shares $2.52 million -16.3%N/A1933.3 $4.34 5/28/2021726,100 shares $3.15 million -11.1%N/A907.6 $4.33 5/14/2021817,000 shares $3.52 million +4.4%N/A907.8 $4.31 4/30/2021782,400 shares $3.45 million -25.9%N/A23.9 $4.40 4/15/20211,056,300 shares $4.45 million -7.3%N/A8.1 $4.21 3/31/20211,139,900 shares $4.92 million -19.0%N/A11.5 $4.31 3/15/20211,408,000 shares $5.95 million -26.0%N/A327.4 $4.23 2/26/20211,902,200 shares $8.07 million -5.1%N/A3804.4 $4.24First JFK… next Elon? (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. 2/12/20212,004,500 shares $8.90 million -29.7%N/A208.8 $4.44 1/29/20212,852,200 shares $12.06 million -37.9%N/A316.9 $4.23 1/15/20213,093,500 shares $12.86 million +6.6%N/A499 $4.16 12/31/20204,594,900 shares $19.30 million +48.5%N/A216.7 $4.20 12/15/20203,093,500 shares $12.69 million +6.6%N/A499 $4.10 11/30/20202,903,000 shares $11.84 million +5.1%N/A205.9 $4.08 11/15/20202,763,400 shares $11.41 million +0.1%N/A307 $4.13 10/30/20202,761,100 shares $11.84 million +11.1%N/A13805.5 $4.29 10/15/20202,485,600 shares $10.76 million -6.1%N/A994.2 $4.33 9/30/20202,647,100 shares $11.54 million +0.6%N/A472.7 $4.36 9/15/20202,630,300 shares $12.27 million +1.6%N/A417.5 $4.67 8/31/20202,590,200 shares $12.32 million -1.3%N/A221.4 $4.76 8/14/20202,625,200 shares $13.43 million +0.7%N/A276.3 $5.12 7/31/20202,606,000 shares $13.59 million -3.9%N/A2004.6 $5.22 7/15/20202,712,700 shares $13.92 million +3.3%N/A1043.3 $5.13 6/30/20202,626,200 shares $14.05 million -0.3%N/A937.9 $5.35 6/15/20202,634,400 shares $13.22 million -2.5%N/A13172 $5.02 5/29/20202,702,300 shares $14.79 million -1.0%N/A27023 $5.47 5/15/20202,728,100 shares $14.43 million +10.0%N/A13640.5 $5.29 4/30/20202,480,300 shares $13.84 million +2.0%N/A729.5 $5.58 4/15/20202,432,900 shares $11.99 million +3.1%N/A1158.5 $4.93 3/31/20202,361,000 shares $13.43 million +8.6%N/A4722 $5.69 3/13/20202,174,400 shares $10.96 million -0.3%N/A258.9 $5.04 2/28/20202,180,000 shares $10.90 million +1.4%N/A660.6 $5.00 2/14/20202,150,300 shares $10.30 million -4.7%N/A212.9 $4.79 1/31/20202,256,500 shares $13.50 million -2.2%N/A1880.4 $5.98 1/15/20201,511,000 shares $8.69 million -9.0%N/A3022 $5.75 12/31/20191,661,200 shares $9.97 million -0.3%N/A48.7 $6.00 KHTRF Short Interest - Frequently Asked Questions What is Knight Therapeutics' current short interest? Short interest is the volume of Knight Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 341,000 shares of KHTRF short. Learn More on Knight Therapeutics' current short interest. What is a good short interest ratio for Knight Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KHTRF shares currently have a short interest ratio of 7.0. Learn More on Knight Therapeutics's short interest ratio. Is Knight Therapeutics' short interest increasing or decreasing? Knight Therapeutics saw a decline in short interest in November. As of November 30th, there was short interest totaling 341,000 shares, a decline of 39.1% from the previous total of 560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Knight Therapeutics stock? Short selling KHTRF is an investing strategy that aims to generate trading profit from Knight Therapeutics as its price is falling. KHTRF shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Knight Therapeutics? A short squeeze for Knight Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KHTRF, which in turn drives the price of the stock up even further. How often is Knight Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KHTRF, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies 1933 Industries Short Interest 4Cable TV International Short Interest 4Front Ventures Short Interest AB Science Short Interest Acreage Short Interest Acreage Short Interest Aleafia Health Short Interest Almirall Short Interest Alvotech Short Interest American Green Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:KHTRF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KHTRF Stock Alerts